GlutDigest - Pilot Study
NCT04489836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2020-10-23
Summary
This is a pilot, feasibility study to evaluate, test and optimize sample analysis procedures and protocols before the full-scale, crossover study is conducted.
Conditions
- Main Focus: Gluten and Starch Digestibility
Interventions
- DIETARY_SUPPLEMENT
-
Glutalytic®
Glutalytic® capsule
- DIETARY_SUPPLEMENT
-
DE111®
DE111® capsule
- OTHER
-
Meal A
Oatmeal porridge - serving of oat porridge (cooked) containing 50g of carbohydrates (excluding sugars); Wheat cereal - serving of wheat cereal providing 1g of gluten; Water - 125 mL
Sponsors & Collaborators
-
Teagasc
collaborator INDUSTRY -
Atlantia Food Clinical Trials
collaborator INDUSTRY -
Deerland Enzymes
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-31
- Primary Completion
- 2020-09-19
- Completion
- 2020-09-19
Countries
- Ireland
Study Locations
More Related Trials
-
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
NCT02389062 ·Status: COMPLETED ·Phase: NA
-
Study of Enzyme Supplements to Treat Celiac Disease
NCT00962182 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of AN-PEP Enzyme on Gluten Digestion
NCT01335503 ·Status: COMPLETED ·Phase: NA
-
Gastric Gluten-Degradation Activity of PvP001
NCT03594331 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of AN-PEP Enzyme on Gluten Digestion in Gluten Sensitive Individuals
NCT02060864 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Larazotide Acetate to Treat Celiac Disease.
NCT00386165 ·Status: COMPLETED ·Phase: PHASE1
-
Bovine Colostrum to Prevent Absorption of Gluten
NCT05555446 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
NCT07298343 ·Status: RECRUITING ·Phase: PHASE2
-
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
NCT06982963 ·Status: RECRUITING ·Phase: PHASE2
-
PTG-100 for Patients With Celiac Disease
NCT04524221 ·Status: COMPLETED ·Phase: PHASE1
-
GlutN : Randomized, Double-blind, Crossover Clinical Trial to Confirm the Role of Gluten in Non-celiac Gluten Sensitivity
NCT06347341 ·Status: TERMINATED ·Phase: NA
-
Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity
NCT01864993 ·Status: COMPLETED ·Phase: NA
-
In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease
NCT03168490 ·Status: TERMINATED ·Phase: NA
-
Dose-finding Gluten Challenge Trial in Nonceliac Gluten-sensitivity
NCT03188367 ·Status: UNKNOWN ·Phase: NA
-
Latiglutenase as a Treatment for Celiac Disease
NCT03585478 ·Status: COMPLETED ·Phase: PHASE2
-
Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response?
NCT07039773 ·Status: RECRUITING ·Phase: NA
-
Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?
NCT06151782 ·Status: COMPLETED ·Phase: NA
-
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
NCT05353985 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of CCX282-B in Patients With Celiac Disease
NCT00540657 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
NCT04530123 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Responses to Gluten
NCT05209568 ·Status: RECRUITING ·Phase: NA
-
A Study of Guselkumab in Adult Participants With Celiac Disease
NCT04704843 ·Status: WITHDRAWN ·Phase: PHASE1
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients
NCT03483805 ·Status: COMPLETED ·Phase: NA